A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer

This study is looking at a new treatment for people with lung cancer that has spread to the brain. Specifically, it's for people whose lung cancer has a particular genetic change (called an EGFR mutation) that makes certain targeted drugs effective. **You may be eligible if...** - You are 18 years or older - You have been newly diagnosed with advanced non-small cell lung cancer (NSCLC) that has not been treated yet - Your cancer has a specific gene change called EGFR 19Del or L858R mutation - Your cancer has spread to the brain - You have at least one tumor that can be measured on a scan **You may NOT be eligible if...** - You have already received treatment for this lung cancer - You do not have the specific EGFR gene mutation Talk to your doctor to see if this trial is right for you.